Get the app!
Back to Trades

Lacey John III

DirectorCIK 0001739761

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
1
Buy transactions
0
Sell transactions
0
Companies
1
Active
2026

Across 1 filing between 2026, Lacey John III, Director, has disclosed $0 in transactions — all concentrated in PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT). Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

1 loaded
Jun 30PVCT
PROVECTUS BIOPHARMACEUTICALS, INC.
Lacey John IIIDirectorAward$0

1 filing